VIPERGEN R & D III K/S: Financial statements 2018
CVR: 30355644
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000. The solvency ratio was 93.3%.
- Gross Profit
- DKK -10,000
- Profit/Loss
- DKK -7,000
- Equity
- DKK 152,000
- Total Assets
- DKK 163,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -10K | -7K | 152K | - |
| 2017 | - | 156K | 211K | 159K | - |
| 2016 | - | - | -52K | -52K | - |
| 2015 | 0 | - | -932K | 0 | - |
| 2014 | 805K | - | -12.3M | 932K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of September 27, 2018, BUUS JENSEN I/S STATSAUTORISEREDE REVISORER has been appointed auditor of VIPERGEN R & D III K/S.
As of September 27, 2018, KPMG P/S has stepped down as auditor of VIPERGEN R & D III K/S.
VIPERGEN R & D III K/S has published its annual report for 2017. Gross profit came to DKK 156,000, and the net result was DKK 211,000.
About VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.
